Bradford D. Dahms

Chief Financial Officer, Selecta Biosciences (United States).

Companies

Jade Biosciences, Inc.Chief financial officer Jul 14, 2025 to now¹
Theseus Pharmaceuticals, Inc.President Feb 14, 2024 to Feb 14, 2024²
Theseus Pharmaceuticals, Inc.Chief financial officer Oct 6, 2021 to Feb 14, 2024³
Selecta Biosciences (United States)Chief financial officer Sep 5, 2019 to Jan 6, 2021⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Jade Biosciences, Inc. JBIO37,813 shares⁵$512.7K at $13.56Feb 12, 2026
Theseus Pharmaceuticals, Inc.0 shares⁶Feb 14, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 12, 2026Granted 37,813 shares of Jade Biosciences, Inc.⁵
Feb 14, 2024U 8,150 shares of Theseus Pharmaceuticals, Inc.⁶
Nov 30, 2022Bought 1,502 shares at $6.66 of Theseus Pharmaceuticals, Inc.⁷
Dec 21, 2021Bought 1,970 shares at $10.15 of Theseus Pharmaceuticals, Inc.⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARJade Biosciences, Inc., Chief financial officer
2
SEC EDGARTheseus Pharmaceuticals, Inc., President
3
SEC EDGARTheseus Pharmaceuticals, Inc., Chief financial officer
4
SEC EDGARSelecta Biosciences (United States), Chief financial officer
5
SEC EDGARJade Biosciences, Inc. shares after the filing of Feb 12, 2026
6
SEC EDGARTheseus Pharmaceuticals, Inc. shares after the filing of Feb 14, 2024
7
SEC EDGARForm 4 filed Dec 1, 2022
8
SEC EDGARForm 4 filed Dec 22, 2021